In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... marked the heavy market focus on the prospect of the White House imposing tariffs on imports from Mexico ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Ore Huiying / Bloomberg / Getty Images Pharmaceutical company Eli Lilly is expected to report ... These include white papers, government data, original reporting, and interviews with industry ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

Thank you for joining us for Eli ... Lilly's chair and CEO; Dr. Dan Skovronsky, chief scientific officer and president of Lilly Immunology; Lucas Montarce, chief financial officer; Anne White ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

The company also said it had appointed appointed Ultimate Fighting Championship CEO Dana White, an ally of US president-elect Donald Trump, as one of three new board members. Zuckerberg appears to ...

Despite strong performances from other pharmaceutical giants like Eli Lilly stock (up 31% ... environment around rate cuts and changes in the White House, could PFE face a similar situation ...

Eli Lilly and Company’s competing weight ... They were joined by RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, and Lyfe Capital.